In 2019 and 2020, the Federal Trade Commission (FTC) reached settlements with the companies responsible for Suboxone, a prescription drug used to treat opioid addiction. The FTC says that these companies violated antitrust laws by preventing patients from choosing lower-priced generic versions of the drug.